REVATIO cpr pell 20 mg 90 pce

7680575050025 CH-57505 G04BE03 02.07.1.

Reimbursement limitations:

REVATIO2

Garantie de prise en charge des coûts par l'assureur-maladie après consultation préalable du médecin-conseil sur …

REVATIO cpr pell 20 mg 90 pce
REVATIO cpr pell 20 mg 90 pce
REVATIO cpr pell 20 mg 90 pce
1 / 3
google

Details

Product number
5750501
CPT
-
Packaging group
90
Unit
Tablette(n)
Composition
sildenafilum 20.00 mg ut sildenafili citras, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium 0.6 mg, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum 0.735 mg, triacetinum, pro compresso obducto.

Articles (1)

Revatio, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/06/2024
Patient information leaflet
Français
24/06/2024
Patient information leaflet
Italien
24/06/2024
Professional SmPC
Allemand
24/06/2024
Professional SmPC
Français
24/06/2024
Professional SmPC
Italien
24/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.6 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.735 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 522.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2007

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
57505
Drug name
Revatio, Filmtabletten
Galenic form
FILM
ATC Code
G04BE03
Authorization status
Z
Dispensation category
B
First authorization
09/11/2006
Authorization expiration date
31/12/9999
IT number
02.07.1.
Domain
Human medicine
Field of application
Behandlung der pulmonalen arteriellen Hypertonie (primäre pulmonale Hypertonie, sowie mit Bindegewebserkrankungen assoziierte PAH) der WHO-Klasse II und III, zur Verbesserung der körperlichen Leistungsfähigkeit

Packaging details

Description (FR)
REVATIO cpr pell 20 mg 90 pce
Description (DE)
REVATIO Filmtabl 20 mg 90 Stk
Market launch
09/11/2006
Narcotic (BTM)
No

Available generics

Sildenafil PAH-Mepha, Filmtabletten
CHF 512.50
View
Sildenafil PAH Spirig HC, Filmtabletten
CHF 512.50
View
Sildenafil PAH Viatris, Filmtabletten
CHF 478.65
View